DAXOR CORP
10-Q/A, 1995-08-04
MISC HEALTH & ALLIED SERVICES, NEC
Previous: CONSUMERS WATER CO, 10-Q, 1995-08-04
Next: DELAWARE GROUP DECATUR FUND INC, N-30D, 1995-08-04



                     SECURITIES AND EXCHANGE COMMISSION

                          	WASHINGTON, D.C.  20549

              	__________________________________________________

                                	FORM 10-Q

                  	Quarterly Report Under Section 13 or 15(d)
	                                  of the
                         	Securities Act of 1934

                      	FOR QUARTER ENDED MARCH 31, 1995
                       	Commission File Number 0-12248


                               	DAXOR CORPORATION

                   	(Exact Name as Specified in its Charter)


                     		     New York 				      13-2682108
       	(State or Other Jurisdiction of       (I.R.S. Employer
         Incorporation or Organization)        Identification No.)

                               	350 Fifth Avenue
                                  	Suite 7120
                            	New York, New York 10118

               (Address of Principal Executive Offices & Zip Code)

            Registrant's Telephone Number:     (212) 244-0555
              (Including Area Code)

	Indicate by check mark whether the registrant (1) has filed all reports 
required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was 
required to file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.

                        Yes  (X)                No      

Indicate the number of shares outstanding of each of the issuer's classes of 
common stock, as of the latest practicable date.

       CLASS                         OUTSTANDING AT MARCH 31, 1995 
   COMMON STOCK                                5,066,630
PAR VALUE: $.O1 per share

<PAGE>
PART I.   FINANCIAL INFORMATION



ITEM 1.   FINANCIAL STATEMENTS                              PAGE

		Consolidated Balance Sheets as at
		  March 31, 1995 and December 31, 1994                      2


		Consolidated Statements of Operations for the
            Three Months Ended March 31, 1995 and 1994        3


		Consolidated Statements of Cash Flows for the
		  Three Months ended March 31, 1995 and 1994                4


		Notes to Financial Statements                               5

		              
		Exhibit 27 - Supplementary exhibit as required
 by the Securities and Exchange Commisiion            Exhibit 1




<PAGE>





                               	SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.



             						DAXOR CORPORATION
          								   (Registrant)




DATE: May 15, 1995                   /s/Joseph Feldschuh, M.D.   
                               								JOSEPH FELDSCHUH, M.D.
                                        President       
 

DATE: May 15, 1995                   /s/  Helen Fajardo          
                                								HELEN FAJARDO 
							                                	Vice President 


DATE: May 15, 1995                   /s/  Octavia Atanasiu       
                                								OCTAVIA ATANASIU    
							                                	Treasurer


DATE: May 15, 1995                  /s/   Stephen D. Feldschuh   
                                								STEPHEN D. FELDSCHUH
							                                	Secretary


<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               MAR-31-1995
<CASH>                                          44,284
<SECURITIES>                                33,379,511
<RECEIVABLES>                                  215,373
<ALLOWANCES>                                         0
<INVENTORY>                                    158,000
<CURRENT-ASSETS>                            34,727,592
<PP&E>                                         999,582
<DEPRECIATION>                                 593,305
<TOTAL-ASSETS>                              35,173,627
<CURRENT-LIABILITIES>                        4,906,586
<BONDS>                                              0
<COMMON>                                        53,097
                                0
                                          0
<OTHER-SE>                                  30,213,944
<TOTAL-LIABILITY-AND-EQUITY>                35,173,627
<SALES>                                        503,480
<TOTAL-REVENUES>                             1,246,502
<CGS>                                          279,363
<TOTAL-COSTS>                                  626,803
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (51,294)
<INCOME-PRETAX>                                619,699
<INCOME-TAX>                                    49,717
<INCOME-CONTINUING>                            569,982
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   569,982
<EPS-PRIMARY>                                      .11
<EPS-DILUTED>                                      .11
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission